Bronchoscopic Valve Management of Persistent Air‐Leaks in Mechanically Ventilated Patients

ABSTRACT Management of persistent air‐leaks (PAL) in mechanically ventilated patients is challenging as most patients are refractory to standard treatments. Herein, we report the successful management of persistent air‐leaks in a case series of seven patients. Patients were mechanically ventilated a...

Full description

Saved in:
Bibliographic Details
Main Authors: Alfonso Fiorelli, Gaetana Messina, Francesca Capasso, Giuseppe Vicario, Davide Pica, Vincenzo Boniello, Massimo Ciaravola, Roberto Alfano, Fausto Ferraro
Format: Article
Language:English
Published: Wiley 2025-07-01
Series:Thoracic Cancer
Subjects:
Online Access:https://doi.org/10.1111/1759-7714.70127
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:ABSTRACT Management of persistent air‐leaks (PAL) in mechanically ventilated patients is challenging as most patients are refractory to standard treatments. Herein, we report the successful management of persistent air‐leaks in a case series of seven patients. Patients were mechanically ventilated and presented severe air‐leaks that persisted 17.5 ± 6.2 days after chest drainage insertion. Patients were deemed unfit for surgical resection while talc pleurodesis was unfeasible in five patients or performed without success in two. Valves treatment was performed at bedside in the Intensive Care Unit. Chest drainage was removed 5.5 ± 3.1 days after valve insertion, and all patients were weaned off the ventilator 8.8 ± 3.4 days later. All but one patient was discharged 26.8 ± 10.2 days following the procedure. One patient died at 35 days due to systemic sepsis not related to valves. Valves were readily removed in four patients at a mean of 149 ± 12.7 days after the implant. Our study confirmed the safe and effective use of EBV treatment for the management of PAL refractory to standard treatment in mechanically ventilated patients.
ISSN:1759-7706
1759-7714